Exact Sciences Corporation (EXAS)

Exact Sciences Corporation (EXAS $101.29)
- $101.29 Cap: $19.19B
- View EXAS Profile
- View Questions on EXAS

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Exact Sciences Corporation (EXAS $101.29)
- $101.29 Cap: $19.19B
- View EXAS Profile
- View Questions on EXAS

Q: Do you recommend moving on at this point given the buyout by Abbott? Would you consider waiting it out until 2026 to defer taxes?

Read Answer Asked by Andrew on November 24, 2025

Exact Sciences Corporation (EXAS $101.29)
- $101.29 Cap: $19.19B
- View EXAS Profile
- View Questions on EXAS
CRISPR Therapeutics AG (CRSP $53.47)
- $53.47 Cap: $5.09B
- View CRSP Profile
- View Questions on CRSP
nVent Electric plc (NVT $107.27)
- $107.27 P/E (TTM): 58.57X Cap: $17.30B
- View NVT Profile
- View Questions on NVT
Shift4 Payments Inc. Class A (FOUR $73.78)
- $73.78 P/E (TTM): 34.64X Cap: $6.53B
- View FOUR Profile
- View Questions on FOUR
Upstart Holdings Inc. (UPST $44.96)
- $44.96 Cap: $4.37B
- View UPST Profile
- View Questions on UPST
Nextpower Inc. (NXT $91.62)
- $91.62 P/E (TTM): 23.8X Cap: $13.59B
- View NXT Profile
- View Questions on NXT
Karman Holdings Inc. (KRMN $67.03)
- $67.03 P/E (TTM): 957.57X Cap: $8.86B
- View KRMN Profile
- View Questions on KRMN

Q: How would you rank the listed companies at current levels for new positions in a growth oriented portfolio?

Read Answer Asked by Andrew on November 04, 2025

Amgen Inc. (AMGN $345.46)
- $345.46 P/E (TTM): 26.68X Cap: $186.02B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $780.19)
- $780.19 P/E (TTM): 18.66X Cap: $81.99B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $433.61)
- $433.61 P/E (TTM): 30.73X Cap: $110.01B
- View VRTX Profile
- View Questions on VRTX
Exact Sciences Corporation (EXAS $101.29)
- $101.29 Cap: $19.19B
- View EXAS Profile
- View Questions on EXAS
iShares Biotechnology ETF (IBB $173.83)
- $173.83 P/E (TTM): 22.53X Cap: $8.57B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $123.16)
- $123.16 P/E (TTM): 18.21X Cap: $7.97B
- View XBI Profile
- View Questions on XBI

Q: Hello 5i,

Wondering if you have any recommendations in the Biometrics category, either ETF or stock? And any particular thoughts regarding current valuations and future prospects versus other opportunities?

Thanks for your feedback.

Ralph

Read Answer Asked by ralph on September 09, 2024